chrisvoncsefalvay/vaers-outcomes huggingface dataset:
two days after receiving the vaccination my left arm went numb. the next am i went to urgent care and they said pinched nerve - no improvement so went to ER on Monday morning. It was determined that the arteries in my left arm were completely blocked and I was not getting any blood flow to limb. Sent from ER and within hours an emergency throbectomy was performed to save my left arm/hand. Spent a couple days in ICU, total 5 in hospital. Doctors DO NOT KNOW if COVID 19 vaccine could have caused or be partially responsible so they advised me to file a report.
it was worse for him after her received the COVID-19 Vaccine shot than having the COVID-19 Virus; it was worse for him after her received the COVID-19 Vaccine shot than having the COVID-19 Virus; This is a spontaneous report from a contactable consumer reported for friend's father. A male patient of unspecified age received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications were not reported. The patient had COVID-19, and also had a severe reaction to the first shot. That was like 10 times worse than Covid itself. He had pretty rough time with it and it was worse for him after her received the COVID-19 Vaccine shot than having the COVID-19 Virus. Outcome of the events was unknown.    Information about lot/batch number has been requested.
Heart rate  172, chest fluttering, went to doctor's appointment, they sent me to hospital, had A fib, they administered iv med, Rate slowed but still  A fib unil next morning.
Patient teste positive for Covid-19 on 06/28/2021, he has been fully vaccinated.
Can this injection cause vertigo; Or vestibular neuritis?; This case was reported by a consumer via call center representative and described the occurrence of vertigo in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced vertigo and vestibular neuronitis. On an unknown date, the outcome of the vertigo and vestibular neuronitis were unknown.   It was unknown if the reporter considered the vertigo and vestibular neuronitis to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but was captured as adult as per vaccine indication.  The patient wanted to know whether shinrix vaccine can cause vertigo and vestibular neuronitis. No other information was reported.
This spontaneous case was reported by a consumer and describes the occurrence of VOMITING PROJECTILE (projectile vomiting) and NAUSEA (nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced VOMITING PROJECTILE (projectile vomiting) and NAUSEA (nausea). At the time of the report, VOMITING PROJECTILE (projectile vomiting) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
I received an immunization for shingles in 2007- In 2008, while on an overseas trip, I came down with shingles in spite of the shot. I would like this to be recorded somewhere for statistical purposes, as a failure for the shot.
8-17-16 AM, patient woke up with sore arm, difficulty moving arm and pain. 8-18-16 Patient slept half of day because of pain, pain subsided a little but still had difficulty moving. 8-19-16 AM Pain decrease, red color appeared from shoulder to elbow. 8-20-16 Redness, redness reducing, arm movement much better, still a little sore.
I?m unsure if these symptoms are related or not to the vaccine but, I want ro report it anyways in case this helps with the collection of data and because I don?t have any symptom of a respiratory viral infection and want to know if it is OK for me to get second dose of the vaccine that is due in 2 weeks or if I should reschedule it. I usually dont get sick and this time I felt pretty bad and had to go to an Urgent Care and ER for treatment for the acute headache af fever at 12 days of getting the first dose of the vaccine. Thanks for your attention to this matter.  Severe headache Fever Chills Bodyaches
Feels awful; Don't feel any good; I got real sick; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Lot number: EW0175) as dose 1, single for covid-19 immunisation. Relevant medical history included: "corona virus", start date: Dec2020 (unspecified if ongoing), notes: I had the corona virus (History) back in December and it was not as bad as taking this vaccine. The patient's concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious), outcome "unknown", described as "Feels awful"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "Don't feel any good"; ILLNESS (non-serious), outcome "unknown", described as "I got real sick". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Consumer stated on call I just wanted to call. I got the vaccine on Tuesday and I had the corona virus (History) back in December and it was not as bad as taking this vaccine. I feel awful. I haven't got the second dose yet. No just the first one. I don't feel any good, I feel awful. I haven't taken the second dose, it's only my first and I got real sick so I don't want to take the second one." Follow-up attempts are completed. No further information is expected.
gave Quadracel to a male patient who is 3 years old; with no AE; Initial information received on 18-Dec-2020 regarding an unsolicited valid non-serious case from a nurse.  This case involves a 3 years old male patient who received diphtheria-15/tetanus/5 hybrid ac pertussis/ipv (mrc5) vaccine [Quadracel] (product administered to patient of inappropriate age).   The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included measles vaccine live (enders-edmonston), mumps vaccine live (jeryl lynn), rubella vaccine live (wistar ra 27/3), varicella zoster vaccine live (oka/merck) (Proquad).  On 18-Sep-2020, the patient of 3 years old received a dose of suspect diphtheria-15/tetanus/5 hybrid ac pertussis/ipv (mrc5) vaccineat a dose of 0.5 ml once (lot C5688AA, with unknown strength, formulation and expiration date) via unknown route in unknown administration site (product administered to patient of inappropriate age).   It is an actual medication error case due to inappropriate age at vaccine administration.   At the time of report, no adverse event was reported.   There will be no information available on the batch number for this case.    This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in directive 2001/83/ec and module VI of the good pharmacovigilance practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Pt vaccinated with DTP developed unusual, prolonged sleeping, 12 hrs straight, after DTP without waking up for any feeding.
I am sneezing maybe three or four times in a row several times a day. Also sneezing at night while sleeping. Mucus blown from nose is clear. Wife had her H1N1 on January 8, 2010 and she is also sneezing. Not as much as I am.
predominant on the left side which is the same side patient; having a rash on both arms more intense on the left side/rash all around the waist more intense on the left side; this is an allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of RASH (having a rash on both arms more intense on the left side/rash all around the waist more intense on the left side), HYPERSENSITIVITY (this is an allergic reaction) and VACCINATION SITE RASH (predominant on the left side which is the same side patient) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037F21A, 004M20A and 011L20) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In November 2021, the patient experienced RASH (having a rash on both arms more intense on the left side/rash all around the waist more intense on the left side) and HYPERSENSITIVITY (this is an allergic reaction). On an unknown date, the patient experienced VACCINATION SITE RASH (predominant on the left side which is the same side patient). At the time of the report, RASH (having a rash on both arms more intense on the left side/rash all around the waist more intense on the left side), HYPERSENSITIVITY (this is an allergic reaction) and VACCINATION SITE RASH (predominant on the left side which is the same side patient) outcome was unknown.            Concomitant medications was not provided by the reporter. Treatment information was not provided.
swollenness in the arm; chest pain; fever; fatigue; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 17-year-old female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported.  The following information was reported: PERIPHERAL SWELLING (non-serious), outcome "unknown", described as "swollenness in the arm"; CHEST PAIN (non-serious), outcome "unknown"; PYREXIA (non-serious), outcome "unknown", described as "fever"; FATIGUE (non-serious), outcome "unknown".  Additional information: The reporter is the parent of the patient. The reporter confirmed product as Trumenba. The caller stated that her daughter's (17-year-old female) experience with the Trumenba was similar to the Pfizer COVID-19 vaccine, stating "she almost didn't have the exact same symptoms as the COVID vaccine, swollenness in the arm, and chest pain, and running fever and a little fatigue".   Transferring agent stated that the caller was a consumer calling about her 17- year-old daughter's reaction to Trumenba. The caller was asking if the Trumenba vaccine was a mRNA vaccine because her daughter had a similar reaction to the COVID Vaccine, a swollen arm and fatigue. The reporter came onto the line and verified information received from the transferring agent. Caller clarified that no, her daughter did not had a similar reaction to a COVID Vaccine; just to that Trumenba, Meningitis B Vaccine. Caller agreed to safety report. The reporter declined to provide mailing address. The caller stated that her daughter received the Trumenba Vaccine 9 or 10 days ago and is totally fine at the time of reporting. Caller stated that she did not call to make a report she just had questions about the vaccine. Caller stated that her daughter had a swollen arm, fatigue, chills, body aches, pain in the upper back. Caller stated that the pain in the upper back seemed bizarre and had the caller worried because she knows people have that kind of pain with a heart attack. Caller was probed for outcome and time frame for all her daughter's symptoms but replied only with saying that her daughter's upper back pain only lasted a couple of hours. Caller then stated that her daughter also had joint pain. Caller asked if these symptoms are normal.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
10 cm patch of erythema at injection site with induration, no drainage and warm, swollen and tender x 5 days and progressing. Pt sent to ER.
3/25/21 second injection dose administered, 3/26/21 body aches, headaches which continued for 36 hours into 3/27/21...between 3/27 and 4/15 no symptoms; 4/16/21 feeling general malaise with  a swollen lymph node in left armpit, additionally muscle pain in chest left side, back left side which continued through 4/17/21...on 4/18/21 small area of light red rash size of half dollar....by the morning of 4/19/21 rash had blistered but area size had not noticeably increased...4/20/21 by the morning concerned the rash looks like possibly shingles, called for appointment to see physician.   Prescription valacyclovir 1 gram 3x per day, 7 day regimen
Shivering muscle ache nerve damage; Shivering muscle ache nerve damage; Shivering muscle ache nerve damage; This serious case was reported by a consumer and described the occurrence of shivering in a 63-year-old male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Concurrent medical conditions included lyme disease. Concomitant products included doxycycline hyclate and prednisone.   On 25-MAY-2023, the patient received Shingles vaccine. On 02-JUN-2023, 8 days after receiving Shingles vaccine, the patient experienced shivering (Verbatim: Shivering muscle ache nerve damage) (serious criteria clinically significant/intervention required), muscle pain (Verbatim: Shivering muscle ache nerve damage) (serious criteria clinically significant/intervention required) and nerve damage (Verbatim: Shivering muscle ache nerve damage) (serious criteria clinically significant/intervention required). The outcome of the shivering, muscle pain and nerve damage were not reported.   It was unknown if the reporter considered the shivering, muscle pain and nerve damage to be related to Shingles vaccine.     It was unknown if the company considered the shivering, muscle pain and nerve damage to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 19-JUN-2023 The patient self-reported this case. The reporter asked he/she would like to know what he/she should do to avoid death. The reporter consented to follow.
This case was reported by a consumer via call center representative and described the occurrence of pneumonia in a 62-year-old female patient who received FLUARIX QUADRIVALENT. On 8th November 2016, the patient received FLUARIX QUADRIVALENT. On 14th November 2016, 6 days after receiving FLUARIX QUADRIVALENT, the patient experienced fever (serious criteria hospitalization). In November 2016, the patient experienced pneumonia (serious criteria hospitalization and GSK medically significant), leukemia (serious criteria hospitalization and GSK medically significant), sickness (serious criteria hospitalization) and chest pain (serious criteria hospitalization). On an unknown date, the patient experienced difficulty breathing (serious criteria hospitalization). The patient was treated with Chemotherapy, nos. In November 2016, The outcome of the chest pain was recovered/resolved. On an unknown date, the outcome of the pneumonia, leukemia, sickness, fever and difficulty breathing were unknown. It was unknown if the reporter considered the pneumonia, leukemia, sickness, fever, difficulty breathing and chest pain to be related to FLUARIX QUADRIVALENT. Additional details were provided as follows: This case was previously reported to a doctor. This case was reported by the patient's daughter. Concomitant medication included high blood pressure medications. The patient received the vaccine in her right arm. Within two days of the vaccination, the patient started to feel sick. She developed chest pain that lasted for four days. On Sunday, 13th November 2016, the patient went to the emergency room (ER). A computerized tomography scan and blood tests were performed. Leukemia cells were detected at this time. She was not admitted and told to follow-up with her physician. On Monday, 14th November 2016, she started having fevers with the maximum temperature reading 101 degrees. On Wednesday, 16th November 2016, the patient saw her physician and he told her she should have been admitted to the hospital and should go back to the hospital to have treatment for the leukemia. She was admitted to the hospital that same day. Chest x-rays at the hospital also showed pneumonia. On Thursday, 17th November 2016, chemotherapy was started and this treatment lasted for seven days. On 5th December 2016, a biopsy was performed, which results showed that there were no leukemia cells. The physician would recheck in another two weeks. The patient was still in the hospital because her lungs were getting worse and the physician was unable to determine what was wrong. A scope of her lungs was performed. At the time of reporting, the patient had a breathing tube. Further details were unable to obtain. The reporter would call back to provide additional details including the lot number and expiration date for the product administered, as well as concomitant medications.
I experienced a breakthrough case of COVID-19 with severe sore throat, headache, chills, fever, fatigue and coughing.
Discharge Provider: , MD Primary Care Provider: , MD Admission Date: 4/19/2023 Discharge Date: Apr 26, 2023   PRESENTING PROBLEM: Generalized weakness COVID-19    HOSPITAL COURSE: Patient is an 91 y/o male with past medical history of anemia, hypertension, and BPH who presented to the emergency department with generalized weakness.  In the emergency department he was afebrile. Chest x-ray showed mild pulmonary venous congestion.  COVID PCR was positive.  He was admitted to the hospitalist service.     He remained asymptomatic from a COVID perspective and did not require further treatment. He had iron studies checked for microcytic anemia and iron deficiency was found.  The patient completed IV iron. Hematology was consulted d/t worsening pancytopenia. It was suspected pancytopenia was likely r/t COVID infection. Nutritional and vitamin deficiencies were evaluated with reassuring B12 and folate levels. Copper and Zinc were collected and pending at time of discharge.   PT/OT evaluated the patient and initially recommended acute rehab at discharge.  PMR was consulted who felt he would be most appropriate for subacute rehab versus progress to home pending functional progress with therapies.  Patient continued to work with therapy while awaiting SAR and he did improve to discharge home with services.     Patient will need follow up with pcp post hospitalization along with repeat cbc in 4-6 weeks, if no improvement in pancytopenia would benefit from outpatient hematology referral. Zinc and Copper levels pending at discharge, if found to be low would benefit from supplementation given this may be contributing to anemia.
Patient reported to be COVID-19 positive on 3/16/21 per medical records. Had cough on and off and fevers for 4 weeks. Remains hospitalized.
On 11/11/03 he developed a vesicular rash which was seen by doctor on 10/12/03.  The lesion were on his posterior and anterior trunk form the neck to the waistline. On 10/28/03 Patient's 4 month old brother was seen by doctor. He has a rash with with red papules and a yellow raised center. There were no vesicles. All the lesions were in the same stage and were located on the trunk, scalp, and neck. Neither boy was ill. The mother reports that she had a positive varicella titer drawn during her pregnancy.
Patient complained of sore arm first.  Then almost immediately passed out for about 45 seconds.  Woke with severe headache, dizziness, sweating, disorientation. Arm still sore after leaving office.
Before getting the J&J vaccination, menstrual periods lasted 2.5 days. The first full period after vaccination, my menstrual periods are now lasting 5 days or more and the blood consistency is much thicker and darker than previously.
This case was reported by a other health professional and described the occurrence of pain in arm in a female patient who received SHINGRIX for prophylaxis. Co-suspect products included Flu Seasonal QIV Dresden for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose and Influenza vaccine Quadrivalent unspecified season at an unknown dose. On 20th September 2018, less than a year after receiving SHINGRIX and unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced pain in arm and influenza-like symptoms. On an unknown date, the outcome of the pain in arm and influenza-like symptoms were unknown. It was unknown if the reporter considered the pain in arm and influenza-like symptoms to be related to SHINGRIX and Influenza vaccine Quadrivalent unspecified season. Additional details were provided as follows: The age at the vaccination was not reported. The patient received Flu shot of unknown brand. The case was linked to the case US2018GSK176991, reported by the same reporter.
right upper outer arm at site of Varicella infjection localized reaction with onset 8-9-07 3:00-4:00 p.m. with redness, induration, and increase skin temperature.  Area increase in size approximately 3" diameter.  8/10/07 Area remained firm and hot and purplish-red in color.  8/11/07 Area resolving with 8/13/07 a red very faded bruised appearance.
It was reported that a pt (9 of 9) received a Tripedia vaccination the week of 3/23/01. Reportedly, sometime after the vaccination (date not specified) the pt developed a large local reaction at the injection site. From additional correspondence received on 5/15/01, it was reported, "unable to locate pt name".
Patient arrived to the Immunizations clinic to receive his Covid Booster. Patients information was verified and he was asked if he has any food or drug allergies and if he has ever had an adverse event to any previous vaccinations. The patient stated no to all questions. Patient then received his Covid Booster and was advised to wait 15min post inoculation. Failure to comply, the patient called an hour after vaccination and  stated that he is experiencing an itchy face and swollen tongue shortly after arriving home. Pt was referred to contact the Nurse Advice Line to get an off-base ER/Urgent Care referral. Pt understood and had no further questions or concerns.